Abbott integrated microchip technology urine correction solution set
Taiwan·Risk Class 2·ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.·Registered Jan 29, 2019 – Jan 29, 2029Active- Analysis ID
- 1de4c0a031a137082c5a246f657c3087
- Customs Code
- DHA05603215306
- Manufacturer
- ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.
- Manufacturer Country
- Canada;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- It is used for the correction of sodium, potassium and chlorine analysis in urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- Input;; Contract manufacturing
- Registration Date
- Jan 29, 2019
- Expiry Date
- Jan 29, 2029
Access comprehensive regulatory information for Abbott integrated microchip technology urine correction solution set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1de4c0a031a137082c5a246f657c3087 and manufactured by ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.